NNSA Mo-99 Stakeholders Meeting
May 16, 2018 — Crystal City Marriott, Arlington, VA
Subscribe to our RSS Feed
- Never miss an important update of the Mo-99 pages. Our RSS 2.0 feed will keep you
informed as soon as we update our information:
Mo-99 Topical Meeting Feed
If you are not familiar with RSS feeds, this website provides a quick introduction in "RSS Explained"
DISCLAIMER
This report was prepared as an account of work sponsored by an agency of the United States
Government. Neither the United States Government nor any agency thereof, nor The University of
Chicago, nor any of their employees or officers, makes any warranty, express or implied, or assumes
any legal liability or responsibility for the accuracy, completeness, or usefulness of any information,
apparatus, product, or process disclosed, or represents that its use would not infringe privately
owned rights. Reference herein to any specific commercial product, process, or service by trade
name, trademark, manufacturer, or otherwise, does not necessarily constitute or imply its endorsement,
recommendation, or favoring by the United States Government or any agency thereof. The views
and opinions of document authors expressed herein do not necessarily state or reflect those of
the United States Government or any agency thereof, Argonne National Laboratory, or The University
of Chicago.
Below you will find the list of available presentations from the 2018 NNSA Mo-99 Stakeholders Meeting. Documents are available for download in pdf format.
# | Paper/Presentation Title | Presenter | Affiliation | Topic |
---|---|---|---|---|
1.1 | Mo-99 Supply Updates [351K B, posted: Aug. 07, 2018 ] | Ira Goldman | Lantheus Medical Imaging | Current U.S. Mo-99 Supply Status - Industry Perspectives |
1.2 | Current Supply Status [533K B, posted: Aug. 07, 2018 ] | Roy Brown | Curium Pharma | Current U.S. Mo-99 Supply Status - Industry Perspectives |
1.3 | Cardinal Health | David Pelliciarini | Cardinal Health | Current U.S. Mo-99 Supply Status - Industry Perspectives |
1.4 | NTP Processing Suspension UPPI Experience [297K B, posted: Aug. 07, 2018 ] | John Witkowski | UPPI | Current U.S. Mo-99 Supply Status - Industry Perspectives |
1.5 | GE Healthcare | Megha Shah | GE Healthcare | Current U.S. Mo-99 Supply Status - Industry Perspectives |
2.1 | IRE LEU Conversion Update [494K B, posted: Aug. 07, 2018 ] | Valery Host | Institute for Radioelements | Conversion Updates |
3.1 | Update on Licensing Reviews Supporting Domestic Molybdenum-99 Production [ 300K B, posted: Aug. 07, 2018 ] | Steven Lynch | NRC | USG Updates |
3.2 | FDA | Eric Duffy | FDA | USG Updates |
3.3 | NNSA Mo-99 Program Update [ 625K B, posted: Aug. 07, 2018 ] | Pete Karcz | DOE/NNSA Mo-99 | USG Updates |
4.1 | SHINE | Katrina Pitas | SHINE | U.S. Cooperative Agreement Partner Updates |
4.2 | NorthStar | Jim Harvey | NorthStar | U.S. Cooperative Agreement Partner Updates |
5.1 | Northwest Medical Isotopes, LLC [ 629K B, posted: Aug. 07, 2018 ] | Carolyn Haass | Northwest Medical Isotopes, LLC | Producer and Stakeholder Updates |
5.2 | Leadership Presentation at Mo-99 Stakeholders Meeting [ 1.2M B, posted: Aug. 07, 2018 ] | Carmen Bigles | Coqui Radiopharmaceuticals | Producer and Stakeholder Updates |
5.3 | Niowave’s Domestic Production of Mo-99 from LEU without a Nuclear Reactor [ 1.6M B, posted: Aug. 07, 2018 ] | Terry Grimm | Niowave | Producer and Stakeholder Updates |
List last updated Aug. 07, 2018 |
Questions?
Please address inquiries to:
Dr. John W. Holland
Argonne National Laboratory
9700 South Cass Avenue, Building 208
Argonne, Illinois 60439-4815
Phone: +1 (630) 252-3079
Fax: +1 (630) 252-5161